| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |